Geneos Wealth Management’s Eaton Vance TaxManaged Buy-Write Strategy Fund EXD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,500
Closed -$24K 2352
2018
Q1
$24K Hold
2,500
﹤0.01% 1323
2017
Q4
$25K Hold
2,500
﹤0.01% 1303
2017
Q3
$28K Hold
2,500
﹤0.01% 1199
2017
Q2
$28K Hold
2,500
﹤0.01% 1148
2017
Q1
$27K Hold
2,500
﹤0.01% 1136
2016
Q4
$28K Hold
2,500
﹤0.01% 1054
2016
Q3
$30K Hold
2,500
﹤0.01% 992
2016
Q2
$30K Hold
2,500
﹤0.01% 990
2016
Q1
$30K Buy
+2,500
New +$31K ﹤0.01% 968

Other funds holding EXD

Geneos Wealth Management's EXD Position: Q2 2018 in Review

Geneos Wealth Management sold out of Eaton Vance TaxManaged Buy-Write Strategy Fund (EXD) in Q2 2018, closing a stake of 2,500 shares — an estimated $24K sold.

Geneos Wealth Management first reported a position in EXD in Q1 2016 and held it in 9 quarters. The position peaked at $30K in Q3 2016. 31 funds tracked by Wall St. Rank hold EXD as of Q2 2018.

  • Geneos Wealth Management reported no remaining Eaton Vance TaxManaged Buy-Write Strategy Fund position as of Q2 2018 after selling out during the quarter.
  • Geneos Wealth Management sold 2,500 Eaton Vance TaxManaged Buy-Write Strategy Fund shares in Q2 2018, an estimated $24K.
  • Geneos Wealth Management first reported a position in Eaton Vance TaxManaged Buy-Write Strategy Fund in Q1 2016 and held it in 9 quarters.
  • Geneos Wealth Management's Eaton Vance TaxManaged Buy-Write Strategy Fund position peaked at $30K in Q3 2016.
  • 31 funds tracked by Wall St. Rank held Eaton Vance TaxManaged Buy-Write Strategy Fund as of Q2 2018.

Based on Geneos Wealth Management's 13F filing for Q2 2018, filed 7 Sep 2021.